drugset
drugset / Trial / NCT06688045

A Study of the Effects of Itraconazole on the Plasma Levels of Nemtabrutinib (MK-1026-013)

NCT06688045 ↗

Phase 1 Completed 15 enrolled Merck Sharp & Dohme LLC
Non-randomizedSequentialOpen-labelBasic science

Summary

The goal of this study is to learn what happens to levels of nemtabrutinib in a person's body over time. Researchers will compare what happens to nemtabrutinib in the body when it is given with or without another medicine called itraconazole.

Timeline

Start
2023-10-30
Primary completion
2024-01-06
Completion
2024-01-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject Nemtabrutinib Other / unclassified — Oral

Indications

No indication recorded.